These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15550886)

  • 1. [The quality-of-life questionnaire QLS-H: validation of the French language version of the questionnaire in patients with growth hormone deficiency and collection of reference data in the general population].
    Rosilio M; Berthezène F; Blum WF; Shavrikova EP; Herschbach P; Henrich G
    Ann Endocrinol (Paris); 2004 Oct; 65(5):439-50. PubMed ID: 15550886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H).
    Rosilio M; Blum WF; Edwards DJ; Shavrikova EP; Valle D; Lamberts SW; Erfurth EM; Webb SM; Ross RJ; Chihara K; Henrich G; Herschbach P; Attanasio AF
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1684-93. PubMed ID: 15070931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and psychometric properties of a disease-specific quality of life questionnaire for adult patients with growth hormone deficiency.
    Herschbach P; Henrich G; Strasburger CJ; Feldmeier H; Marín F; Attanasio AM; Blum WF
    Eur J Endocrinol; 2001 Sep; 145(3):255-65. PubMed ID: 11517005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased quality of life in adult patients with growth hormone deficiency compared with general populations using the new, validated, self-weighted questionnaire, questions on life satisfaction hypopituitarism module.
    Blum WF; Shavrikova EP; Edwards DJ; Rosilio M; Hartman ML; Marín F; Valle D; van der Lely AJ; Attanasio AF; Strasburger CJ; Henrich G; Herschbach P
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4158-67. PubMed ID: 12970281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurements of quality of life in patients with growth hormone deficiency.
    Webb SM
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):52-5. PubMed ID: 19020387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of long-term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH-deficient adults.
    Gilchrist FJ; Murray RD; Shalet SM
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):363-70. PubMed ID: 12201829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year change in quality of life in adults on growth hormone replacement for growth hormone deficiency: an analysis of the hypopituitary control and complications study.
    Mo D; Blum WF; Rosilio M; Webb SM; Qi R; Strasburger CJ
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4581-8. PubMed ID: 25233155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Polish version of the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) - four-stage translation and validation.
    Karbownik-Lewińska M; Lewiński A; McKenna S; Kokoszko A; Mucha S; Komorowski J; Krzyzanowska-Swiniarska B; Gryczyńska M; Sowiński J; Junik R; Meads D; Kołtowska-Häggström M
    Endokrynol Pol; 2008; 59(5):374-84. PubMed ID: 18979446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pilot study and preliminary validation of the French version of a quality-of-life questionnaire specific for subjects with growth hormone deficiency].
    Leplège A; Ecosse E; Archambau F; Arlot S; Bachelot I; Bercovici JP; Bouchard P; Colle M; Dewailly D; Hassler P; Lorcy Y; Luton JP; Roger P; Valensi P; Schaison G
    Ann Endocrinol (Paris); 2003 Jun; 64(3):191-7. PubMed ID: 12910060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Growth hormone deficiency in adults: effects of replacement therapy on body composition and health-related quality of life].
    Mesa J; Gómez JM; Hernández C; Picó A; Ulied A;
    Med Clin (Barc); 2003 Jan; 120(2):41-6. PubMed ID: 12570912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-I bioactivity might reflect different aspects of quality of life than total IGF-I in GH-deficient patients during GH treatment.
    Varewijck AJ; Lamberts SW; Neggers SJ; Hofland LJ; Janssen JA
    J Clin Endocrinol Metab; 2013 Feb; 98(2):761-8. PubMed ID: 23295465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric properties of two measures of psychological well-being in adult growth hormone deficiency.
    McMillan CV; Bradley C; Gibney J; Russell-Jones DL; Sönksen PH
    Health Qual Life Outcomes; 2006 Mar; 4():16. PubMed ID: 16553952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the disease-specific Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) questionnaire in a general population: results from a French panel study.
    Gilet H; Chachuat A; Viala-Danten M; Auzière S; Koltowska-Häggström M
    Value Health; 2010; 13(4):495-500. PubMed ID: 20102556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological effects of withdrawal of growth hormone therapy from adults with growth hormone deficiency.
    McMillan CV; Bradley C; Gibney J; Healy ML; Russell-Jones DL; Sönksen PH
    Clin Endocrinol (Oxf); 2003 Oct; 59(4):467-75. PubMed ID: 14510909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influences on quality of life in GH deficient adults and their effect on response to treatment.
    Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Smethurst LE; Shalet SM
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The brazilian version of the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA): Four-stage translation and validation.
    Ribeiro-Oliveira A; Mol SS; Twiss J; Alencar GA; Miranda PA; Naves LA; Azevedo MF; Basílio FM; Boguszewski CL; Nogueira KC; Vilar L; Koltowska-Haggstrom M; McKenna SP
    Arq Bras Endocrinol Metabol; 2010 Dec; 54(9):833-41. PubMed ID: 21340177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in childhood onset growth hormone-deficient patients in the transition phase from childhood to adulthood.
    Attanasio AF; Shavrikova EP; Blum WF; Shalet SM
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4525-9. PubMed ID: 15899956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the French version of the arthritis impact measurement scales 2 and comparison with the french version of the Nottingham Health Profile. "Quality of Life in Rheumatology" Task Force.
    Pouchot J; Guillemin F; Coste J; Brégeon C; Sany J
    Rev Rhum Engl Ed; 1996 Jun; 63(6):389-404. PubMed ID: 8817749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults--comparison between Sweden, The Netherlands and Germany.
    Saller B; Mattsson AF; Kann PH; Koppeschaar HP; Svensson J; Pompen M; Koltowska-Häggström M; ; ;
    Eur J Endocrinol; 2006 Jun; 154(6):843-50. PubMed ID: 16728544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Japanese version of the Quality of Life-Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA).
    Suzukamo Y; Noguchi H; Takahashi N; Shimatsu A; Chihara K; Green J; Fukuhara S
    Growth Horm IGF Res; 2006; 16(5-6):340-7. PubMed ID: 17081792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.